IL-33/ST2 drives inflammatory pain via CCL2 signaling and activation of TRPV1 and TRPM8

Abstract Innate immunity is the first line of host defense and contributes to pain. However, how innate immune system interacts with sensory neurons to govern pain remains poorly understood. Here, we report that interleukin 33(IL-33) initiates pain hypersensitivity that requires chemokine (C-C motif...

Full description

Saved in:
Bibliographic Details
Main Authors: Linjie Wang, Jingyun Zhang, Shijuan Qiu, Ruizhen Huang, Yuge Wang, Yuting Wang, Mingyu Li, Qingqing Ye, Sibo Zhang, Zhenhua Qi, Lan Cao, Guohao Li, Yajie An, Denghui Xie, Wenli Mi, Huaqiao Wang, Tao Luo, Jingdun Xie, Junting Huang
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Communications Biology
Online Access:https://doi.org/10.1038/s42003-025-08119-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849342368386383872
author Linjie Wang
Jingyun Zhang
Shijuan Qiu
Ruizhen Huang
Yuge Wang
Yuting Wang
Mingyu Li
Qingqing Ye
Sibo Zhang
Zhenhua Qi
Lan Cao
Guohao Li
Yajie An
Denghui Xie
Wenli Mi
Huaqiao Wang
Tao Luo
Jingdun Xie
Junting Huang
author_facet Linjie Wang
Jingyun Zhang
Shijuan Qiu
Ruizhen Huang
Yuge Wang
Yuting Wang
Mingyu Li
Qingqing Ye
Sibo Zhang
Zhenhua Qi
Lan Cao
Guohao Li
Yajie An
Denghui Xie
Wenli Mi
Huaqiao Wang
Tao Luo
Jingdun Xie
Junting Huang
author_sort Linjie Wang
collection DOAJ
description Abstract Innate immunity is the first line of host defense and contributes to pain. However, how innate immune system interacts with sensory neurons to govern pain remains poorly understood. Here, we report that interleukin 33(IL-33) initiates pain hypersensitivity that requires chemokine (C-C motif) ligand 2 (CCL2) secretion from infiltrated macrophages and neutrophils and activation of transient receptor potential vanilloid 1 (TRPV1) and transient receptor potential melastatin 8 (TRPM8) channels in sensory neurons. Blocking CCL2 receptor (CCR2) attenuates IL-33- induced and Complete Freund’s adjuvant (CFA)-induced thermal hyperalgesia and blocking TRPV1 and TRPM8 attenuates IL-33-induced mechanical and thermal hypersensitivity and cold allodynia respectively. Furthermore, depletion of macrophages reduces IL-33-induced pain and expression of CCL2 and suppression of tumorigenicity 2 (ST2) in hindpaw skin and inhibition of CCR2 prevents recruitment of macrophages and neutrophils. Our findings reveal an unrecognized neuroimmune crosstalk of IL-33-CCL2 signaling from infiltrated immune cells with TRPV1/TRPM8 in sensory neurons to facilitate pain states.
format Article
id doaj-art-2cec9e3daa1b4fbbb703d6d6b6387dcf
institution Kabale University
issn 2399-3642
language English
publishDate 2025-05-01
publisher Nature Portfolio
record_format Article
series Communications Biology
spelling doaj-art-2cec9e3daa1b4fbbb703d6d6b6387dcf2025-08-20T03:43:26ZengNature PortfolioCommunications Biology2399-36422025-05-018111510.1038/s42003-025-08119-3IL-33/ST2 drives inflammatory pain via CCL2 signaling and activation of TRPV1 and TRPM8Linjie Wang0Jingyun Zhang1Shijuan Qiu2Ruizhen Huang3Yuge Wang4Yuting Wang5Mingyu Li6Qingqing Ye7Sibo Zhang8Zhenhua Qi9Lan Cao10Guohao Li11Yajie An12Denghui Xie13Wenli Mi14Huaqiao Wang15Tao Luo16Jingdun Xie17Junting Huang18Department of Human Anatomy and Physiology, Zhongshan School of Medicine, Sun Yat-Sen UniversityDepartment of Human Anatomy and Physiology, Zhongshan School of Medicine, Sun Yat-Sen UniversityDepartment of Human Anatomy and Physiology, Zhongshan School of Medicine, Sun Yat-Sen UniversityDepartment of Human Anatomy and Physiology, Zhongshan School of Medicine, Sun Yat-Sen UniversityDepartment of Human Anatomy and Physiology, Zhongshan School of Medicine, Sun Yat-Sen UniversityDepartment of Human Anatomy and Physiology, Zhongshan School of Medicine, Sun Yat-Sen UniversityDepartment of Human Anatomy and Physiology, Zhongshan School of Medicine, Sun Yat-Sen UniversityDepartment of Anesthesiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer CenterFoshan Clinical Medical School, Guangzhou University of Chinese MedicineDepartment of Anesthesiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer CenterDepartment of Human Anatomy and Physiology, Zhongshan School of Medicine, Sun Yat-Sen UniversityDepartment of Joint Surgery and Sports Medicine, Center for Orthopedic Surgery, Orthopedic Hospital of Guangdong Province, The Third Affiliated Hospital of Southern Medical UniversityDepartment of Human Anatomy and Physiology, Zhongshan School of Medicine, Sun Yat-Sen UniversityDepartment of Joint Surgery and Sports Medicine, Center for Orthopedic Surgery, Orthopedic Hospital of Guangdong Province, The Third Affiliated Hospital of Southern Medical UniversityDepartment of Integrative Medicine and Neurobiology, School of Basic Medical Sciences, Shanghai Medical College, Institutes of Integrative Medicine, Fudan UniversityDepartment of Human Anatomy and Physiology, Zhongshan School of Medicine, Sun Yat-Sen UniversityDepartment of Human Anatomy and Physiology, Zhongshan School of Medicine, Sun Yat-Sen UniversityDepartment of Anesthesiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer CenterDepartment of Human Anatomy and Physiology, Zhongshan School of Medicine, Sun Yat-Sen UniversityAbstract Innate immunity is the first line of host defense and contributes to pain. However, how innate immune system interacts with sensory neurons to govern pain remains poorly understood. Here, we report that interleukin 33(IL-33) initiates pain hypersensitivity that requires chemokine (C-C motif) ligand 2 (CCL2) secretion from infiltrated macrophages and neutrophils and activation of transient receptor potential vanilloid 1 (TRPV1) and transient receptor potential melastatin 8 (TRPM8) channels in sensory neurons. Blocking CCL2 receptor (CCR2) attenuates IL-33- induced and Complete Freund’s adjuvant (CFA)-induced thermal hyperalgesia and blocking TRPV1 and TRPM8 attenuates IL-33-induced mechanical and thermal hypersensitivity and cold allodynia respectively. Furthermore, depletion of macrophages reduces IL-33-induced pain and expression of CCL2 and suppression of tumorigenicity 2 (ST2) in hindpaw skin and inhibition of CCR2 prevents recruitment of macrophages and neutrophils. Our findings reveal an unrecognized neuroimmune crosstalk of IL-33-CCL2 signaling from infiltrated immune cells with TRPV1/TRPM8 in sensory neurons to facilitate pain states.https://doi.org/10.1038/s42003-025-08119-3
spellingShingle Linjie Wang
Jingyun Zhang
Shijuan Qiu
Ruizhen Huang
Yuge Wang
Yuting Wang
Mingyu Li
Qingqing Ye
Sibo Zhang
Zhenhua Qi
Lan Cao
Guohao Li
Yajie An
Denghui Xie
Wenli Mi
Huaqiao Wang
Tao Luo
Jingdun Xie
Junting Huang
IL-33/ST2 drives inflammatory pain via CCL2 signaling and activation of TRPV1 and TRPM8
Communications Biology
title IL-33/ST2 drives inflammatory pain via CCL2 signaling and activation of TRPV1 and TRPM8
title_full IL-33/ST2 drives inflammatory pain via CCL2 signaling and activation of TRPV1 and TRPM8
title_fullStr IL-33/ST2 drives inflammatory pain via CCL2 signaling and activation of TRPV1 and TRPM8
title_full_unstemmed IL-33/ST2 drives inflammatory pain via CCL2 signaling and activation of TRPV1 and TRPM8
title_short IL-33/ST2 drives inflammatory pain via CCL2 signaling and activation of TRPV1 and TRPM8
title_sort il 33 st2 drives inflammatory pain via ccl2 signaling and activation of trpv1 and trpm8
url https://doi.org/10.1038/s42003-025-08119-3
work_keys_str_mv AT linjiewang il33st2drivesinflammatorypainviaccl2signalingandactivationoftrpv1andtrpm8
AT jingyunzhang il33st2drivesinflammatorypainviaccl2signalingandactivationoftrpv1andtrpm8
AT shijuanqiu il33st2drivesinflammatorypainviaccl2signalingandactivationoftrpv1andtrpm8
AT ruizhenhuang il33st2drivesinflammatorypainviaccl2signalingandactivationoftrpv1andtrpm8
AT yugewang il33st2drivesinflammatorypainviaccl2signalingandactivationoftrpv1andtrpm8
AT yutingwang il33st2drivesinflammatorypainviaccl2signalingandactivationoftrpv1andtrpm8
AT mingyuli il33st2drivesinflammatorypainviaccl2signalingandactivationoftrpv1andtrpm8
AT qingqingye il33st2drivesinflammatorypainviaccl2signalingandactivationoftrpv1andtrpm8
AT sibozhang il33st2drivesinflammatorypainviaccl2signalingandactivationoftrpv1andtrpm8
AT zhenhuaqi il33st2drivesinflammatorypainviaccl2signalingandactivationoftrpv1andtrpm8
AT lancao il33st2drivesinflammatorypainviaccl2signalingandactivationoftrpv1andtrpm8
AT guohaoli il33st2drivesinflammatorypainviaccl2signalingandactivationoftrpv1andtrpm8
AT yajiean il33st2drivesinflammatorypainviaccl2signalingandactivationoftrpv1andtrpm8
AT denghuixie il33st2drivesinflammatorypainviaccl2signalingandactivationoftrpv1andtrpm8
AT wenlimi il33st2drivesinflammatorypainviaccl2signalingandactivationoftrpv1andtrpm8
AT huaqiaowang il33st2drivesinflammatorypainviaccl2signalingandactivationoftrpv1andtrpm8
AT taoluo il33st2drivesinflammatorypainviaccl2signalingandactivationoftrpv1andtrpm8
AT jingdunxie il33st2drivesinflammatorypainviaccl2signalingandactivationoftrpv1andtrpm8
AT juntinghuang il33st2drivesinflammatorypainviaccl2signalingandactivationoftrpv1andtrpm8